Targeting PCSK9 reduces cancer cell stemness and enhances antitumor immunity in head and neck cancer
Author:
Funder
National Natural Science Foundation of China
Natural Science Foundation of Hubei Province
Fundamental Research Funds for the Central Universities
Publisher
Elsevier BV
Subject
Multidisciplinary
Reference60 articles.
1. Head and neck squamous cell carcinoma;Johnson;Nat. Rev. Dis. Prim.,2020
2. Cancer statistics, 2022;Siegel;Ca - Cancer J. Clin.,2022
3. Immunology and immunotherapy of head and neck cancer;Ferris;J. Clin. Oncol.,2015
4. Oral cavity and oropharyngeal squamous cell carcinoma--an update;Chi;Ca - Cancer J. Clin.,2015
5. A subnetwork-based framework for prioritizing and evaluating prognostic gene modules from cancer transcriptome data;Cao;iScience,2023
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Serum PCSK9 is a novel serological biomarker for the diagnosis and prognosis of pancreatic cancer;PeerJ;2024-09-10
2. The multifaceted role of PCSK9 in cancer pathogenesis, tumor immunity, and immunotherapy;Medical Oncology;2024-07-15
3. Prognostic Value of PCSK9 Levels in Premenopausal Women at Risk of Breast Cancer—Evidence from a 17-Year Follow-Up Study;Cancers;2024-04-04
4. Potential use of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibition and prevention method in viral infection;Microbial Cell Factories;2024-03-25
5. An innovative gene expression modulating strategy by converting nucleic acids into HNC therapeutics using carrier-free nanoparticles;Frontiers in Immunology;2024-01-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3